BDRX

Biodexa Pharmaceuticals plc

0.8733

+0.2593+42.23%

Suspension19:49 04/02 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.9235/0.6140

TODAY RANGE0.8008-1.350

VOL121.23M

MARKET CAP2.83M

52 WEEK RANGE0.6005-19.30

AVG VOL (3M)2.20M

% TURNOVER3,739.78%

TURNOVER--

P/E (TTM)-0.0012

% RANGE89.45%

EPS(TTM)-707.3844

P/E(FORWARD)-0.2766

P/B0.0035

BVPS253.07

DIVIDEND--

P/S230.39

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP538.90K

SHARES OUTSTANDING3.24M

NEXT EARNINGS--

FREE FLOAT617.09K

LOT SIZE1

EX-DATE04/06/2026

News

Press Releases

Financial Reports

Profile

TipRanks·1d ago
Biodexa Pharmaceuticals PLC-ADR trading halted, news pending
NASDAQ·2d ago
Biodexa Pharmaceuticals Stock Surges 69% Over Partnership With Syngene International
TipRanks·2d ago
Biodexa Pharmaceuticals announces MTX240 manufacturing pact with Syngene
TipRanks·4d ago
Biodexa, Tanner Pharma launch global early access program for FAP patients
TipRanks·03/27 21:59
Biodexa Pharmaceuticals Posts 2025 Preliminary Results and Deepens GI Cancer-Focused Pipeline
TipRanks·03/23 14:45
Biodexa Pharmaceuticals management to meet with Maxim
TipRanks·03/18 22:00
Biodexa Pharmaceuticals Announces Reverse ADR Split to Support Nasdaq Compliance
Seeking Alpha·03/18 21:10
Biodexa Pharmaceuticals announces ADR ratio change
TipRanks·03/18 21:10
Biodexa Pharmaceuticals announces one-for-five reverse ADR split
TipRanks·03/09 12:40
Biodexa Pharmaceuticals supports Life’s a Polyp Foundation
TipRanks·02/04 13:57
Biodexa Licenses Otsuka’s Phase 1‑Ready Molecular Glue MTX240 for GIST
TipRanks·02/04 13:36
Biodexa Pharmaceuticals announces exclusive license with Otsuka Pharmaceutical
TipRanks·01/06 21:28
Biodexa Pharmaceuticals Names Fiona Sharp CFO and Board Director
NASDAQ·01/05 14:32
Biodexa Promotes Fiona Sharp To CFO As Stephen Stamp Cedes Role To Become Only CEO
TipRanks·01/05 13:57
Biodexa Pharmaceuticals Promotes Fiona Sharp to CFO and Board Director

Same Industry

Name/Symbol

Change%

Price

BDRX

REGN

GRDX

BNTX

UTHR

VRTX

SIGA

MRNA

CRL

MEDP

Talphera Inc

TLPH

-7.12%

0.7223

ICLR

CBPO

IQV

MOLN

Arcturus Therape

ARCT

+2.29%

8.03

GILD

PRAH

INCY

APVO

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.